ST. PAUL, Minn., June 21, 2012 — (BUSINESSWIRE) — Minnetronix has unveiled its new website and brand strategy today to better reflect the company’s growth and its advancement of intellectual property within the medical device industry.

Minnetronix has a 16-year history of significant value creation for its customers and will add to its established medical device development and manufacturing capabilities as it licenses and creates novel technology and intellectual property for the benefit of its customers and patients. Minnetronix’ growing “IP Innovations” enterprise will advance the organization’s mission of enhancing patient outcomes through medical device technology.

“For over 15 years, Minnetronix has been dedicated to making a positive impact on patient lives by developing and delivering technical solutions for its customers. As we continue to evolve, we can provide even greater value to patients and medical device companies by identifying and developing new and unique progressive technologies,” remarked Rich Nazarian, Minnetronix President & CEO.

“Minnetronix has excelled at bringing clients’ proprietary solutions to the marketplace and that will continue to be our focus. We are now in a position to contribute and deliver even more clinically impactful and differentiating innovations as well. We feel the combination of our well established engineering and manufacturing services, with our intellectual property pipeline, creates great potential for effective clinical solutions.”

Minnetronix’ first IP Innovations licensing agreement was recently signed with Penn State Research Foundation for its wireless energy transmission technology. This technology facilitates more mobile and fully implantable systems for use in assist devices in the treatment of End-Stage Heart Disease and Congestive Heart Failure.